Inspection Record

New England Home Therapies, Inc. — FDA 483 Findings

US FDAInspected 2016-03-17Published 2025-06-20 8 findingsTraining and personnelComplaint and recall handlingAseptic processing and sterility assuranceDeviation, CAPA, and investigationEquipment and facility

Inspectors Edmund F MrakThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Training and personnel

Clothing of personnel engaged in the processing of drug products is not appropriate for the duties they perform.

2Complaint and recall handling

Procedures describing the handling of written and oral complaints related to drug products are deficiently written or followed.

3Aseptic processing and sterility assurance

Aseptic processing areas are deficient regarding the system for monitoring environmental conditions.

4Deviation, CAPA, and investigation

There is a failure to thoroughly review any unexplained discrepancy whether or not the batch has been already distributed.

5Aseptic processing and sterility assurance

Aseptic processing areas are deficient regarding the system for cleaning and disinfecting the room and equipment to produce aseptic conditions.

6Aseptic processing and sterility assurance

Procedures designed to prevent microbiological contamination of drug products purporting to be sterile d o not include validation of the sterilization process.

7Equipment and facility

Equipment and utensils are not maintained at appropriate intervals to prevent contamination that would alter the safety, identity, strength, quality or purity of the drug product.

8Equipment and facility

Routine calibration of mechanical and electronic equipment is not performed according to a written program designed to assure proper perfor mance.

About this record

Extracted automatically from the document US FDA published on 2025-06-20. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

New England Home Therapies, Inc. company profile — full history US FDA documents, 2025 Go to Findings search